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Abstract
Background: The measurement of lactate in emergency medical services has the potential for earlier detection of
shock and can be performed with a point-of-care handheld device. Validation of a point-of-care handheld device is
required for prehospital implementation.
Aim: The primary aim was to validate the accuracy of Lactate Pro 2 in healthy volunteers and in haemodynamically
compromised intensive care patients. The secondary aim was to evaluate which sample site, fingertip or earlobe, is
most accurate compared to arterial lactate.
Methods: Arterial, venous and capillary blood samples from fingertips and earlobes were collected from intensive care
patients and healthy volunteers. Arterial and venous blood lactate samples were analysed on a stationary hospital blood
gas analyser (ABL800 Flex) as the reference device and compared to the Lactate Pro 2. We used the Bland-Altman
method to calculate the limits of agreement and used mixed effect models to compare instruments and sample sites. A
total of 49 intensive care patients with elevated lactate and 11 healthy volunteers with elevated lactate were included.
Results: There was no significant difference in measured lactate between Lactate Pro 2 and the reference method using
arterial blood in either the healthy volunteers or the intensive care patients. Capillary lactate measurement in the fingertip
and earlobe of intensive care patients was 47% (95% CI (29 to 68%), p < 0.001) and 27% (95% CI (11 to 45%), p < 0.001)
higher, respectively, than the corresponding arterial blood lactate. In the healthy volunteers, we found that capillary blood
lactate in the fingertip was 14% higher than arterial blood lactate (95% CI (4 to 24%), p = 0.003) and no significant
difference between capillary blood lactate in the earlobe and arterial blood lactate.
Conclusion: Our results showed that the handheld Lactate Pro 2 had good agreement with the reference method using
arterial blood in both intensive care patients and healthy volunteers. However, we found that the agreement was poorer
using venous blood in both groups. Furthermore, the earlobe may be a better sample site than the fingertip in intensive
care patients.
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Background
Circulatory shock is usually divided in categories accord-
ing to the etiology that causes circulatory failure. The
cause of circulatory shock among trauma patients is
often hypovolemia due to blood loss, while the etiology
of non-traumatic shock may be more complex. Circula-
tory failure and shock develop as the perfusion and oxy-
gen delivery to the organs and tissues decrease and is
insufficient to meet the metabolic demand. When oxy-
gen delivery is below a critical level, shock occurs with
the accumulation of oxygen debt. Occult shock is the
state of early hypoperfusion causing metabolic acidosis,
that may occur in patients prior to detectable changes in
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vital signs. Due to insufficient oxygen delivery to the tis-
sues, anaerobic metabolism leads to the production of
lactate [1, 2].
Circulatory failure following both non-traumatic condi-
tions and trauma is common in the prehospital setting, and
the mortality rates in patients presenting with shock in the
emergency departments are high. Correct initial assessment
and identification of shock followed by early resuscitation is
important to improve survival of these patients [3, 4].
Prehospital monitoring of vital signs such as systolic
blood pressure (SBP) and heart rate (HR) are main indi-
cators used to identify shock. However, such vital signs
often do not change until a patient is near a critical
stage, and therefore often fail to predict shock at an early
stage [5–7]. Blood lactate monitoring is widely accepted
in-hospital as an indirect marker of tissue hypoxia in
critically ill patients. The Surviving Sepsis Campaign
Guidelines use a cut-off value of greater than 4mmol/L
lactate for early resuscitation therapy to treat sepsis [8].
Lactate levels are commonly measured during resuscita-
tion to predict mortality and to evaluate and guide treat-
ment in the emergency department (ED) and the
intensive care unit (ICU). However, lactate levels are in-
frequently measured in the prehospital setting [9, 10].
Recent prehospital studies suggest that lactate may be
more sensitive than SBP and HR in identifying haemor-
rhagic shock patients who may benefit from early blood
transfusion, and suggest that lactate may be independent
of conventional vital signs in identifying these patients
[10–14]. Implementation of point of care lactate monitors
in emergency medical services (EMS) may contribute to
the evaluation of patients in the early stages of shock,
thereby establishing a trigger for resuscitation [15, 16].
The primary aim of this study was to validate the
handheld device Lactate Pro 2 (LP2) in two different
groups: healthy volunteers and critically ill patients. The
secondary aims were to compare capillary blood lactate
in the fingertip and earlobe with arterial blood lactate to




This is a prospective observational study. The study was per-
formed with two groups: haemodynamically compromised
intensive care patients and healthy volunteers performing a
maximal oxygen consumption test (VO2 max test). The
healthy volunteer group had a longitudinal study design with
repeated measurements over a short period of time.
Setting
The study took place in the Intensive Care Unit, Haukeland
University Hospital, Norway. The healthy volunteers were
tested at the VO2 test laboratory at the same hospital. The
study was conducted from September 2016 to February
2018.
Participants
Patients were enrolled from the ICU at Haukeland
University Hospital. Inclusion criteria for intensive care
patients were (i) adults at least 18 years of age, (ii) an
arterial line and a central venous catheter, and (iii)
informed consent from the next of kin or the patient
him- or herself if awake and competent to give consent.
Healthy volunteers were enrolled from the medical fac-
ulty in Bergens sports team. Inclusion criteria for the
healthy volunteers included were (i) adults at least 18
years of age and (ii) informed consent.
Sampling
Blood gases from the arterial and central venous lines of
the ICU patients were sampled in heparinized syringes
by the ICU nurses. They were analysed on both the LP2
and the ABL800 Flex (ABL) immediately. Capillary
blood was drawn from the fingertip and earlobe and
analysed on the LP2. Two LP2 instruments, denoted
LP2.1 and LP2.2, were used for quality assessment: the
first drop of blood was measured on the LP2.1 and the
second on LP2.2. In one ICU patient only one arterial
and one venous sample was drawn. Two capillary sam-
ples each from fingertip and earlobe were sampled. All
capillary samples were measured by author A.R. The
timing of sampling with respect to day of ICU treatment
was not registered, but the patients were included
shortly after ICU admission. The healthy volunteers
underwent a VO2-max test on treadmill (Modified
Bruce Protocol) with an arterial line and a peripheral
venous catheter during the test [17]. Repeated measure-
ments of arterial, venous and capillary blood lactate in
this group were recorded at rest, directly after the VO2-
max test and at 3, 5, 10 and 20 min after the test was
completed. Capillary blood samples were drawn from
the fingertip and earlobe. The arterial and venous blood
samples were drawn in heparin tubes, stored on ice and
analysed on the ABL within 30 min.
Materials
Lactate Pro 2 (AKRAY Europe B.V. Prof J.H Bavincklaan
51,183 AT, Amstelveen, the Netherlands) is a handheld
point-of care analyser that operates by enzymatic amper-
ometric detection. Blood lactate reacts with the reagent
on the test strip, which produces a small electrical
current proportional to the concentration of blood lac-
tate. The meter measures this current and calculates the
blood lactate level. It requires 0.3 μl of a whole-blood
sample and 15 s to measure the lactate value. LP2 has a
measurement range between 0.5–25.0 mmol/L. If “Hi” or
“Lo” appears on the display it means that the blood
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lactate level is above 25.0 mmol/L or below 0.5 mmol/L,
respectively. Therefore, in this study only lactate values
between 0.5 and 25 were included.
ABL800 Flex (Radiometer Medical ApS, Åkandevej 21,
DK-2700 Brønshøj, Denmark) is the standard blood gas
machine used in the ICU at Haukeland University Hos-
pital. It uses an amperometric method to measure the
lactate value. The enzyme lactate oxidase converts lac-
tate to H2O2 and the oxidation of H2O2 produces an
electrical current that is directly related to the amount
of lactate. The analyser thereby automatically calculates
the lactate concentration in the sample.
Statistical methods
Logarithmic transformation was performed for lactate
since lactate has a skewed distribution and logarithmic-
ally transformed lactate is closer to normal distribution.
Due to the repeated measurements in each individual in
the healthy volunteer group, a mixed effects model, with
log transformed lactate as dependent variable, with in-
strument and time as independent variables was used.
Fixed effect coefficients were exponentially transformed
to be interpretable as ratios. First, we estimated a model
with the same difference between instruments at all time
points and then a model when this was not assumed.
For ICU patients, mixed effects models were used for
the measurements at different sites and with different in-
struments, and Bland-Altman plots were used to com-
pare different instruments and different sites [18].
Calculations were performed with R (R Foundation for
Statistical Computing, Vienna, Austria) using the R
package nlme for mixed effects analysis [19].
Results
Forty-nine ICU patients and 11 healthy volunteers were
included. Of the healthy volunteers there were 4 women
and 7 men. The mean age was 24.5 years (Table 1). In
the ICU patients there were 41 missing values (6.3%), in-
cluding 34 values above the detection limit. In the
healthy volunteers, there were 10 missing values (2.5%),
including 4 values above the detection limit.
Instrument comparisons
In the ICU group (n = 49), we found no significant dif-
ference in measured lactate between the LP2 and the
ABL using arterial blood (Table 2, Fig. 1). We found sig-
nificantly higher values with LP2 than ABL using central
venous blood (Table 2, Fig. 2).
In the healthy volunteer group (n = 11), we found no
significant difference between LP2 and ABL using arter-
ial blood but significantly higher values for LP2 when
using peripheral venous blood (Table 2). We found no
statistically significant difference between LP2.2 and
LP2.1 in both arterial and venous blood. In a mixed
effects model where the instrument discrepancy could
vary during follow-up, LP2 measured lower values in ar-
terial blood compared to ABL at “rest” (data not shown),
but we found no significant difference between LP2 and
ABL at the other time points.
Sample site comparisons
In the ICU group, we found significant differences in
both fingertip and earlobe compared to arterial blood
using the LP2.1. Capillary blood lactate in the fingertip
and earlobe was 47% (95% CI (29 to 68%), p < 0.001) and
27% (95% CI (11 to 45%), p < 0.001) higher than in arter-
ial blood, respectively (Table 3). When comparing





Mean age 62.0 ± 17.1 years
Diagnosis
Sepsis 15 (30.6%)
Hypovolemic shock 4 (8.2%)
Trauma 4 (8.2%)
Respiratory failure 3 (6.1%)
Severe burn injury 3 (6.1%)
Cardiogenic shock 4 (8.2%)
Other 11 (22.4%)
NA 5 (10.2%)
Table 2 Results of instrument comparisons with arterial and
venous blood in ICU patients and healthy volunteers
Estimate (Ratio) 95% CI p-value
ICU patients
Arterial
LP2.1 vs ABL 1.03 0.99 to 1.08 0.140
LP2.2 vs ABL 1.04 0.99 to 1.09 0.102
LP2.2 vs LP2.1 1.004 0.96 to 1.05 0.871
Venous
LP2.1 vs ABL 1.29 1.24 to 1.35 < 0.001
LP2.2 vs ABL 1.29 1.23 to 1.35 < 0.001
LP2.2 vs LP2.1 0.998 0.96 to 1.04 0.938
Healthy volunteers
Arterial, LP2 vs ABL 0.96 0.93 to 1.002 0.063
Venous, LP2 vs ABL 1.07 1.03 to 1.11 0.001
The results presented in the table are based on mixed effects models with log
transformed lactate as the dependent variable. The ratios presented are based
on fixed effect coefficients, exponentially transformed to be interpretable as
ratios. For example, arterial lactate measurements on the instrument LP2.1 are
estimated as 3% higher than measurements on the ABL in ICU patients
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fingertip to earlobe we found that capillary blood lactate
in the fingertip was 16% higher than in the earlobe (95%
CI (2 to 32%), p = 0.029). Bland Altman plots for com-
parison between capillary blood lactate in fingertip with
arterial blood lactate on both handheld instruments
(LP2.1 and LP2.2) in the ICU group are presented in
Fig. 3. We observed a rise in the lactate values in the
fingertip from the first blood drop measured on LP2.1 to
the second blood drop measured on LP2.2. We did not
observe the same effect in the earlobe.
In the healthy volunteer group (n = 11), we found that
capillary blood lactate in the fingertip was 14% higher
than arterial blood lactate (95% CI (4 to 24%), p = 0.003)
(Table 3). We found no significant difference between
capillary blood lactate in the earlobe and arterial blood
lactate (Table 3).
Discussion
The LP2 and ABL agreed well in arterial blood taken
from both healthy volunteers and intensive care patients.
Capillary blood lactate values in the fingertip were sig-
nificantly higher than the corresponding arterial values
in both ICU patients and healthy volunteers. Capillary
blood lactate values in the earlobe were significantly
higher than arterial blood lactate values in the ICU
group but not in the healthy volunteer group.
The earlobe seems to be a better sample site than the
fingertip, possibly because it is more central than the
fingertip. More importantly, it is less sensitive to vari-
ation between two measurements taken consecutively.
Contenti et al. used the earlobe as sample site and found
that capillary blood lactate was higher than both venous
and arterial lactate [20]. In our study, ICU patients had
Fig. 1 Bland-Altman plot for instrument comparison of LP2 and ABL in arterial blood from ICU patients, based on log transformed lactate
Fig. 2 Bland-Altman plot for instrument comparison of LP2 and ABL in venous blood from ICU patients, based on log transformed lactate
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higher capillary blood lactate than arterial blood lactate
but almost the same as venous blood lactate.
Studies performed with other handheld devices in ICU
populations also report good agreement between capil-
lary and arterial lactate, but these devices were validated
in lower lactate ranges [21–23].
Collange et al. is the only other study that com-
pared both capillary and arterial blood samples on a
handheld device instead of comparing capillary blood
measured on a handheld device with arterial blood
measured on a reference method. Like us, they found
that capillary lactate was higher than arterial blood
lactate. However, in contrast to our findings, they re-
ported that the handheld instrument measured
slightly lower lactate values than the reference instru-
ment using arterial blood [22].
Lactate monitoring in EMS may help the provider to
detect shock at an earlier stage and may be used as an
early trigger for blood transfusion in haemorrhaging pa-
tients or for fluid therapy in septic patients [14]. In gen-
eral, arterial blood is preferred. Capillary lactate should
only be measured when rapid measurement is necessary
or when arterial blood is not available. Since patients in
the prehospital setting in most cases do not receive an
arterial line, a handheld capillary blood lactate measur-
ing device may be well suited for EMS services. Measur-
ing lactate values in the field is quick and should not
delay other treatments or interventions on-scene. Our
results show that LP2 has the potential to overestimate
the lactate values, which may lead to overtreatment or
over-triage of patients. This may, however, be of less im-
portance than the potential consequences of under-
triage in situations where EMS providers fail to detect
early stages of shock.
Despite overestimation of the actual value in a single
reading, this value may be helpful as an adjunct to other
vital signs during assessment of these patients. Further,
multiple readings may provide more information be-
cause a lactate trend may reflect the clinical course of
shock and the effect of resuscitation. This may be valu-
able in clinical decision making and to guide treatment.
When interpreting lactate values, one must consider
both the instrumental bias of the LP2 and the physio-
logical discrepancy between arterial and capillary blood
Table 3 Results of sample site comparisons in ICU patients and
healthy volunteers
Estimate (Ratio) 95% CI p-value
ICU patients
Finger LP2.1 vs Arterial LP2.1 1.47 1.29 to 1.68 < 0.001
Earlobe LP2.1 vs Arterial LP2.1 1.27 1.11 to 1.45 < 0.001
Finger LP2.2 vs Arterial LP2.2 1.85 1.55 to 2.21 < 0.001
Earlobe LP2.2 vs Arterial LP2.2 1.22 1.03 to 1.46 0.024
Finger LP2.1 vs Venous LP2.1 1.14 1.01 to 1.30 0.040
Earlobe LP2.1 vs Venous LP2.1 0.99 0.87 to 1.12 0.871
Finger LP2.2 vs Venous LP2.2 1.43 1.20 to 1.69 < 0.001
Earlobe LP2.2 vs Venous LP2.2 0.95 0.80 to 1.13 0.569
Healthy volunteers
Finger vs arterial 1.14 1.04 to 1.24 0.003
Earlobe vs arterial 0.98 0.90 to 1.06 0.568
The results presented in the table are based on mixed effects models with log
transformed lactate as the dependent variable. The ratios presented are based
on fixed effect coefficients, exponentially transformed to be interpretable as
ratios. For example, lactate measurements from the fingertip are estimated as
47% higher than arterial measurements in ICU patients
Fig. 3 Bland-Altman plots for comparison between lactate in fingertip with arterial lactate in ICU patients, based on log transformed lactate
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lactate values in different sample sites and in different
haemodynamical states.
Strengths and limitations
The strength of this study lies in the standardized pro-
cedure for collecting blood and analysing lactate. In con-
trast to other studies comparing capillary and arterial
blood lactate we measured both capillary and arterial/
venous blood on the same instrument. Most other stud-
ies compare capillary lactate measured on the handheld
device with the arterial value measured by the reference
method. We believe our method is more correct because
it separates the instrument agreement from the differ-
ence in the blood samples. We also validated the LP2 in
a wide range of lactate values (from 0.5–25.0 mmol/l) in
both healthy volunteers and intensive care patients,
which shows the differences in lactate distribution in ca-
pillary and arterial/venous blood in these two haemo-
dynamically different groups. This study has some
limitations of note. We have previously observed that
cold LP2 strips may influence the measured value ran-
domly; therefore, we made sure that the LP2 and the
strips were stored at room temperature. This limitation
in the instrument may have caused a bias in patients
with low body temperature. We are considering further
research on this issue. The manufacturer states that the
device must be used between 5 and 40 degrees Celsius
and should be adjusted to the surroundings for at least
20 min. In the pre-hospital environment, the
temperature may exceed these limits. This requires the
device to be stored in a temperature-controlled environ-
ment, e.g. in an isolated casing.
Regarding capillary measurements, the disinfecting
agent can cause haemolysis, which may increase the lac-
tate concentration. This study includes few study sub-
jects, which limits the generalizability of the study
findings. The number of healthy volunteers included is
low due to the ethical aspect of arterial cannulation and
the associated risk of complication. The number of miss-
ing values in our data set, partly due to the detection
limits of the LP2 also constitutes a limitation.
Conclusion
We found that Lactate Pro 2 had good agreement with
the reference method using arterial blood but poorer
agreement using venous blood. Our results show the po-
tential for overestimation of the lactate values in haemo-
dynamically compromised patients. The levels of lactate
in capillary blood from the fingertip and earlobe were 47
and 27% higher, respectively, than arterial lactate in in-
tensive care patients. The earlobe may be a better sam-
ple site than the fingertip in haemodynamically
compromised patients.
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